EMA workshop report on the future of vaccine effectiveness studies in Europe
Submitted by Anonymous (not verified) on 16 October 2024 - 9:45
EMA workshop report on the future of vaccine effectiveness studies in Europe
HMPC meeting report on European Union herbal monographs, guidelines and other activities - 23-25 September 2024
Submitted by Anonymous (not verified) on 16 October 2024 - 9:33
HMPC meeting report on European Union herbal monographs, guidelines and other activities - 23-25 September 2024
Human medicines European public assessment report (EPAR): Clopidogrel Zentiva (previously Clopidogrel Winthrop), clopidogrel, Date of authorisation: 15/07/2008, Revision: 33, Status: Authorised
Submitted by Anonymous (not verified) on 15 October 2024 - 15:46
Human medicines European public assessment report (EPAR): Clopidogrel Zentiva (previously Clopidogrel Winthrop), clopidogrel, Date of authorisation: 15/07/2008, Revision: 33, Status: Authorised
Agenda - PDCO agenda of the 15-18 October 2024 meeting
Submitted by Anonymous (not verified) on 15 October 2024 - 15:31
Agenda - PDCO agenda of the 15-18 October 2024 meeting
Article 57 product data
Submitted by Anonymous (not verified) on 15 October 2024 - 15:24
Article 57 product data
Orphan designation: Fosmanogepix Treatment of fusariosis, 15/02/2023 Positive
Submitted by Anonymous (not verified) on 15 October 2024 - 10:33
Orphan designation: Fosmanogepix Treatment of fusariosis, 15/02/2023 Positive
Orphan designation: Heterologous human adult liver derived stem cells Treatment of ornithinine transcarbamylase deficiency, 04/02/2008 Positive
Submitted by Anonymous (not verified) on 15 October 2024 - 10:09
Orphan designation: Heterologous human adult liver derived stem cells Treatment of ornithinine transcarbamylase deficiency, 04/02/2008 Positive
Orphan designation: Heterologous human adult liver-derived progenitor cells Treatment of citrullinaemia type 1, 17/07/2013 Positive
Submitted by Anonymous (not verified) on 15 October 2024 - 9:40
Orphan designation: Heterologous human adult liver-derived progenitor cells Treatment of citrullinaemia type 1, 17/07/2013 Positive
Orphan designation: Heterologous human adult liver-derived stem cells Treatment of Crigler-Najjar syndrome, 29/11/2007 Positive
Submitted by Anonymous (not verified) on 15 October 2024 - 8:00
Orphan designation: Heterologous human adult liver-derived stem cells Treatment of Crigler-Najjar syndrome, 29/11/2007 Positive
Orphan designation: Heterologous human adult liver-derived progenitor cells Treatment of hyperargininaemia, 17/07/2013 Positive
Submitted by Anonymous (not verified) on 15 October 2024 - 8:00
Orphan designation: Heterologous human adult liver-derived progenitor cells Treatment of hyperargininaemia, 17/07/2013 Positive